Washington University School of Medicine Digital Commons@Becker Open Access Publications 2019 Therapeutic efficacy of favipiravir against Bourbon virus in mice Traci L. Bricker Md. Shafiuddin Anshu P. Gounder Andrew B. Janowski Guoyan Zhao See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Authors Traci L. Bricker, Md. Shafiuddin, Anshu P. Gounder, Andrew B. Janowski, Guoyan Zhao, Graham D. Williams, Brett .W Jagger, Michael S. Diamond, Thomas Bailey, Jennie H. Kwon, David Wang, and Adrianus C. M. Boon RESEARCH ARTICLE Therapeutic efficacy of favipiravir against Bourbon virus in mice 1 1 1,2 2 Traci L. BrickerID , Md. Shafiuddin , Anshu P. Gounder , Andrew B. JanowskiID , 3 1,2 1 1,2,3 Guoyan ZhaoID , Graham D. WilliamsID , Brett W. JaggerID , Michael S. DiamondID , 1 1 2,3 1,2,3 Thomas Bailey , Jennie H. Kwon , David WangID , Adrianus C. M. BoonID * 1 Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America, 2 Department of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri, United States of America, 3 Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America a1111111111 a1111111111 *
[email protected] a1111111111 a1111111111 a1111111111 Abstract Bourbon virus (BRBV) is an emerging tick-borne RNA virus in the orthomyxoviridae family that was discovered in 2014. Although fatal human cases of BRBV have been described, OPEN ACCESS little is known about its pathogenesis, and no antiviral therapies or vaccines exist. We obtained serum from a fatal case in 2017 and successfully recovered the second human Citation: Bricker TL, Shafiuddin M., Gounder AP, Janowski AB, Zhao G, Williams GD, et al.